Experiment: 2KVK

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
2	2D 1H-13C HSQC aliphatic	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O	100% D2O	50	6.5	ambient	298
3	3D CBCA(CO)NH	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
4	3D HNCACB	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
5	3D HNCO	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
6	3D HN(CA)CO	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
7	3D HCCH-TOCSY	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
8	3D H(CCO)NH	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
9	3D C(CO)NH	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
10	3D 1H-15N NOESY	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
11	3D 1H-13C NOESY aliphatic	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O	100% D2O	50	6.5	ambient	298
12	3D 1H-13C NOESY aromatic	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O	100% D2O	50	6.5	ambient	298
13	2D HB(CBCGCD)HD	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
14	2D HB(CBCGCE)HE	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O	95% H2O/5% D2O	50	6.5	ambient	298
15	2D 1H-13C HSQC aromatic	20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O	100% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
torsion angle dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	processing	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	CARA	1.8.4	Keller and Wuthrich
4	structure solution	TALOS	TALOS+	Cornilescu, Delaglio and Bax
5	structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
6	data analysis	PSVS	1.4	Bhattacharya and Montelione
7	refinement	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
8	refinement	TALOS	TALOS+	Cornilescu, Delaglio and Bax
9	refinement	CING		Vuister et al.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.